Rebecca Taub
2020
In 2020, Rebecca Taub earned a total compensation of $3.9M as President, Research &Development and Chief Medical Officer at Synta Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $339,230 |
---|---|
Option Awards | $3,052,280 |
Salary | $490,833 |
Total | $3,882,343 |
Taub received $3.1M in option awards, accounting for 79% of the total pay in 2020.
Taub also received $339.2K in non-equity incentive plan and $490.8K in salary.
Rankings
In 2020, Rebecca Taub's compensation ranked 2,949th out of 13,090 executives tracked by ExecPay. In other words, Taub earned more than 77.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,949 | 78th |
Manufacturing | 1,144 | 80th |
Chemicals And Allied Products | 425 | 81st |
Drugs | 368 | 81st |
Pharmaceutical Preparations | 271 | 81st |
Taub's colleagues
We found four more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2020.